acrizanib   Click here for help

GtoPdb Ligand ID: 12782

Synonyms: compound 35 [PMID: 29400470] | LHA-510 | LHA510
Compound class: Synthetic organic
Comment: Acrizanib (LHA510) is a small-molecule VEGFR2 inhibitor that was developed to block occular neovascularization in age-related macular degeneration (wAMD) [1]. It can be delivered as topical eye drops, in contrast to the anti-VEGF biologics that are used to treat wAMD which are administered as invasive intravitreal injections.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 93.92
Molecular weight 445.4
XLogP 0.67
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CNCC1=NC=NC(=C1)OC2=CC3=C(C=C2)N(C=C3)C(=O)NC4=NN(C)C(=C4)C(F)(F)F
Isomeric SMILES O=C(NC=1C=C(C(F)(F)F)N(N1)C)N2C=CC3=C2C=CC(=C3)OC4=NC=NC(CNC)=C4
InChI InChI=1S/C20H18F3N7O2/c1-24-10-13-8-18(26-11-25-13)32-14-3-4-15-12(7-14)5-6-30(15)19(31)27-17-9-16(20(21,22)23)29(2)28-17/h3-9,11,24H,10H2,1-2H3,(H,27,28,31)
InChI Key XPIHPLVWOUDMPF-UHFFFAOYSA-N
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
kinase insert domain receptor Hs Inhibitor Inhibition 7.8 pIC50 - 1
pIC50 7.8 (IC50 1.74x10-8 M) [1]
Description: Determined in a Ba/F3 VEGFR2 cellular proliferation assay